Emergent BioSolutions, Inc. (EBS)
11.87
-0.03
(-0.25%)
USD |
NYSE |
Dec 08, 16:00
11.63
-0.24
(-2.02%)
Pre-Market: 08:27
Emergent BioSolutions Profit Margin (Quarterly): 22.15% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 14.07% |
| SIGA Technologies, Inc. | -243.0% |
| Tonix Pharmaceuticals Holding Corp. | -972.9% |
| GeoVax Labs, Inc. | -- |
| Black Diamond Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.25% |
| Return on Assets | 5.29% |
| Return on Invested Capital | 6.29% |
| Gross Profit Margin (Quarterly) | 55.86% |
| Operating Margin (Quarterly) | 33.23% |
| Return on Net Operating Assets | 6.30% |